High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
Authors
Keywords
-
Journal
Cancer Cell International
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-11
DOI
10.1186/s12935-022-02508-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
- (2021) Wei Xu et al. Cancer Cell International
- CDCA8 as an independent predictor for a poor prognosis in liver cancer
- (2021) Yu Shuai et al. Cancer Cell International
- Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
- (2021) Giulia De Conti et al. Cancers
- Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
- (2021) Yuan Cheng et al. Molecular Cancer
- ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer
- (2021) Hanxi Yi et al. JOURNAL OF NANOBIOTECHNOLOGY
- Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
- (2021) Zhenqing Wang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
- (2021) Jianjun Xu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy
- (2021) Lihua Luo et al. JOURNAL OF NANOBIOTECHNOLOGY
- Cimetidine a promising radio‐protective agent through modulating Bax/Bcl2 ratio: An in vivo study in male rats
- (2020) Suzanne Estaphan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Multifunctional TPP-PEG-biotin self-assembled nanoparticle drug delivery-based combination therapeutic approach for co-targeting of GRP78 and lysosome
- (2020) Baskaran Purushothaman et al. JOURNAL OF NANOBIOTECHNOLOGY
- Strengthened Tumor Photodynamic Therapy Based on a Visible Nanoscale Covalent Organic Polymer Engineered by Microwave Assisted Synthesis
- (2020) Yao Lu et al. ADVANCED FUNCTIONAL MATERIALS
- The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer
- (2020) Ji-jun Fu et al. JOURNAL OF NANOBIOTECHNOLOGY
- pH-responsive and hyaluronic acid-functionalized metal–organic frameworks for therapy of osteoarthritis
- (2020) Feng Xiong et al. JOURNAL OF NANOBIOTECHNOLOGY
- The mTOR/ULK1 signaling pathway mediates the autophagy-promoting and osteogenic effects of dicalcium silicate nanoparticles
- (2020) Wang Ruolan et al. JOURNAL OF NANOBIOTECHNOLOGY
- RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
- (2020) Yueyue Yang et al. Cancer Cell International
- CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma
- (2020) Chenyue Zhang et al. Cancer Cell International
- Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway
- (2020) Xin Wu et al. Cancer Cell International
- Emerging nanomedicines for effective breast cancer immunotherapy
- (2020) Amirhossein Bahreyni et al. JOURNAL OF NANOBIOTECHNOLOGY
- Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma
- (2019) Bin Yu et al. PATHOLOGY RESEARCH AND PRACTICE
- Methylation of C/EBPα by PRMT1 inhibits its tumor suppressive function in breast cancer
- (2019) Li-ming Liu et al. CANCER RESEARCH
- Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
- (2019) Gregor Sturm et al. BIOINFORMATICS
- Overriding adaptive resistance to sorafenib via combination therapy with SHP2 blockade in hepatocellular carcinoma
- (2019) Carmen Oi Ning Leung et al. HEPATOLOGY
- Lysosomal membrane permeabilization and cell death
- (2018) Fengjuan Wang et al. TRAFFIC
- PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer.
- (2018) Vito W Rebecca et al. Cancer Discovery
- M 4 IDP, a zoledronic acid derivative, induces G1 arrest, apoptosis and autophagy in HCT116 colon carcinoma cells via blocking PI3K/Akt/mTOR pathway
- (2017) Ying Peng et al. LIFE SCIENCES
- Regulation of heat shock transcription factors and their roles in physiology and disease
- (2017) Rocio Gomez-Pastor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Combined autophagy and HDAC inhibition
- (2014) Devalingam Mahalingam et al. Autophagy
- Combined MTOR and autophagy inhibition
- (2014) Reshma Rangwala et al. Autophagy
- Interplay of Acetyltransferase EP300 and the Proteasome System in Regulating Heat Shock Transcription Factor 1
- (2014) Swasti Raychaudhuri et al. CELL
- Heat Shock Protein 70.1 (Hsp70.1) Affects Neuronal Cell Fate by Regulating Lysosomal Acid Sphingomyelinase
- (2014) Hong Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
- (2014) Xiao-Hong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- ScatterJ: An ImageJ plugin for the evaluation of analytical microscopy datasets
- (2014) F. ZEITVOGEL et al. JOURNAL OF MICROSCOPY
- Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
- (2012) Angela Gauthier et al. HEPATOLOGY RESEARCH
- mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis
- (2012) Shiuh-Dih Chou et al. PLoS One
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
- (2011) Ying-Hong Shi et al. Autophagy
- Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
- (2011) Satoshi Shimizu et al. INTERNATIONAL JOURNAL OF CANCER
- Hsp70.1 and related lysosomal factors for necrotic neuronal death
- (2011) Tetsumori Yamashima JOURNAL OF NEUROCHEMISTRY
- The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
- (2011) T. Yau et al. ONCOLOGIST
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started